[go: up one dir, main page]

NO980211D0 - Opplösning av 1-azabicyklo£2.2.2|oktan-3-amin,2-(difenylmetyl)-N-££2-metoksy-5-(1-metyletyl)fenyl|metyl| - Google Patents

Opplösning av 1-azabicyklo£2.2.2|oktan-3-amin,2-(difenylmetyl)-N-££2-metoksy-5-(1-metyletyl)fenyl|metyl|

Info

Publication number
NO980211D0
NO980211D0 NO980211A NO980211A NO980211D0 NO 980211 D0 NO980211 D0 NO 980211D0 NO 980211 A NO980211 A NO 980211A NO 980211 A NO980211 A NO 980211A NO 980211 D0 NO980211 D0 NO 980211D0
Authority
NO
Norway
Prior art keywords
diphenylmethyl
azabicyclo
methylethyl
octane
methoxy
Prior art date
Application number
NO980211A
Other languages
English (en)
Other versions
NO980211L (no
Inventor
Derek L Tickner
Morgan Meltz
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO980211D0 publication Critical patent/NO980211D0/no
Publication of NO980211L publication Critical patent/NO980211L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
NO980211A 1995-07-17 1998-01-16 Opplösning av 1-azabicyklo£2,2,2|oktan-3-amin, 2-(difenylmetyl)-N-££2-metoksy-5-(1-metyletyl)fenyl|metyl| NO980211L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US119195P 1995-07-17 1995-07-17
PCT/IB1996/000648 WO1997003984A1 (en) 1995-07-17 1996-07-04 Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-n-[[2-methoxy-5-(1-methylethyl)phenyl]methyl]

Publications (2)

Publication Number Publication Date
NO980211D0 true NO980211D0 (no) 1998-01-16
NO980211L NO980211L (no) 1998-03-16

Family

ID=21694832

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980211A NO980211L (no) 1995-07-17 1998-01-16 Opplösning av 1-azabicyklo£2,2,2|oktan-3-amin, 2-(difenylmetyl)-N-££2-metoksy-5-(1-metyletyl)fenyl|metyl|

Country Status (25)

Country Link
US (1) US6008357A (no)
EP (1) EP0840735B1 (no)
JP (1) JP3043074B2 (no)
KR (1) KR100276989B1 (no)
CN (1) CN1068598C (no)
AR (1) AR002772A1 (no)
AT (1) ATE250600T1 (no)
AU (1) AU697553B2 (no)
CA (1) CA2227194C (no)
CO (1) CO4480720A1 (no)
CZ (1) CZ15098A3 (no)
DE (1) DE69630123T2 (no)
DK (1) DK0840735T3 (no)
ES (1) ES2205039T3 (no)
HU (1) HUP9900238A3 (no)
IL (1) IL122655A0 (no)
MY (1) MY115734A (no)
NO (1) NO980211L (no)
NZ (1) NZ310539A (no)
PE (1) PE8798A1 (no)
PL (1) PL184261B1 (no)
PT (1) PT840735E (no)
RU (1) RU2136681C1 (no)
WO (1) WO1997003984A1 (no)
ZA (1) ZA966026B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2005252A3 (cs) * 2002-09-25 2005-11-16 Memory Pharmaceuticals Corporation Indazoly, benzothiazoly a benzoisothiazoly jejich příprava a použití
US6861526B2 (en) * 2002-10-16 2005-03-01 Pfizer Inc. Process for the preparation of (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine
RU2320659C9 (ru) * 2004-02-02 2008-07-20 Пфайзер Продактс Инк. Способы получения 1-(2s, 3s)-2-бензгидрил-n-(5-трет-бутил-2-метоксибензил)хинуклидин-3-амина в виде камфорсульфатной соли, цитратной соли и свободного основания и промежуточное соединение
CA2581863A1 (en) * 2004-11-10 2006-05-26 Boehringer Ingelheim Chemicals, Inc. Process of making fentanyl intermediates
US20110301159A1 (en) * 2008-12-09 2011-12-08 University Of South Florida Kinase inhibitor compounds
US20160332962A1 (en) 2015-05-13 2016-11-17 Janssen Pharmaceutica Nv (s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
CN108341812A (zh) * 2017-01-23 2018-07-31 科贝源(北京)生物医药科技有限公司 一种含奎宁环化合物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990005525A1 (en) * 1988-11-23 1990-05-31 Pfizer Inc. Quinuclidine derivatives as substance p antagonists
NO168529C (no) * 1989-09-15 1992-03-04 Chiron Lab As Fremgangsmaate for fremstilling av s-(-) og r-(+)-n-(quinuclidinyl-3)-amider.
PL172069B1 (pl) * 1991-05-22 1997-07-31 Pfizer Sposób wytwarzania nowych pochodnych podstawionej 3-aminochinuklidyny PL PL PL PL PL
JPH0733386B2 (ja) * 1991-05-31 1995-04-12 フアイザー・インコーポレイテツド キヌクリジン誘導体
US5604241A (en) * 1992-10-21 1997-02-18 Pfizer Inc. Substituted benzylaminoquinuclidines as substance P antagonists

Also Published As

Publication number Publication date
AU697553B2 (en) 1998-10-08
EP0840735A1 (en) 1998-05-13
CN1190970A (zh) 1998-08-19
NZ310539A (en) 1998-11-25
DE69630123T2 (de) 2004-04-08
PT840735E (pt) 2004-02-27
DK0840735T3 (da) 2004-02-09
CA2227194A1 (en) 1997-02-06
NO980211L (no) 1998-03-16
CO4480720A1 (es) 1997-07-09
CZ15098A3 (cs) 1999-02-17
IL122655A0 (en) 1998-08-16
EP0840735B1 (en) 2003-09-24
PE8798A1 (es) 1998-03-02
US6008357A (en) 1999-12-28
JP3043074B2 (ja) 2000-05-22
MY115734A (en) 2003-08-30
JPH10511102A (ja) 1998-10-27
CN1068598C (zh) 2001-07-18
RU2136681C1 (ru) 1999-09-10
HUP9900238A2 (hu) 1999-05-28
KR100276989B1 (ko) 2001-01-15
HK1010195A1 (en) 1999-06-17
ZA966026B (en) 1998-01-16
PL324610A1 (en) 1998-06-08
ATE250600T1 (de) 2003-10-15
MX9800538A (es) 1998-05-31
KR19990029058A (ko) 1999-04-15
AR002772A1 (es) 1998-04-29
ES2205039T3 (es) 2004-05-01
CA2227194C (en) 2002-02-12
AU6134896A (en) 1997-02-18
WO1997003984A1 (en) 1997-02-06
PL184261B1 (pl) 2002-09-30
DE69630123D1 (en) 2003-10-30
HUP9900238A3 (en) 2001-08-28

Similar Documents

Publication Publication Date Title
NO2007001I2 (no) Pioglitazon/metformin.
NO965020L (no) Opprettholdelse av sammensetningen av overförte data ved overlevering
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
DE69504516D1 (de) Verschleissfester überzug
CY2007024I2 (el) Kαινοφανη παραγωγα 3.3-διαφαινυλοπροπυλινων
AU1816495A (en) (4,4-difluorobut-3-enylthio)-substituted heterocyclic or carbocyclic ring compounds having pesticidal activity
FI973440L (fi) Trisubstituoituja fenyylijohdannaisia
NO951442D0 (no) 3,5-disubstituerte tetrahydrofuran-2-oner
TR199600849A2 (tr) 1alfa-26 dihidroksi -D-homo-vitamin D3.
ITBO970640A0 (it) Apparecchio per l'elettroemanazione di principi attivi.
FR2687753B1 (fr) Soufflet notamment pour joints homocinetiques.
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
DK0824535T3 (da) Antibakterielle cephalosporinforbindelser.
FI971674A0 (fi) Heterosyklisen ryhmän sisältämät di-tert-butyyli-fenoliyhdisteet, käyttökelpoisia tulehduksenvastaisina aineina
DE59609043D1 (de) Feste Lösungen von 1,4-Diketopyrrolopyrrolen
IT1302243B1 (it) Sintesi dell'1,1,1,3,3-pentafluoropropano.
NO980211D0 (no) Opplösning av 1-azabicyklo£2.2.2|oktan-3-amin,2-(difenylmetyl)-N-££2-metoksy-5-(1-metyletyl)fenyl|metyl|
IT1274571B (it) Procedimento per la preparazione di ¬r-(r*,r*)|-5-(3-clorofenil)-3- ¬2-(3,4-dimetossifenil)-1-metil-etil|-ossazolidin-2-one
DE69618045D1 (de) Clavulansäure Salz
FR2726854B1 (fr) Facade mobile notamment pour la fermeture d'espaces de rangement ou de meubles
DE69619812D1 (de) Kontinuierliche herstellung von 1,1-difluorethan
DE69828906D1 (de) Herstellung von 1,3 propandiolestern
NO980316D0 (no) Fremgangsmåte for fremstilling av polymerisater av N-vinylkarprolaktam
ID16434A (id) Senyawa-senyawa 1,4-dihidropiridin
ZA974929B (en) New forms of organic salts of N'N-diacetylcystine.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application